Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated versus conventional chemoradiotherapy for head and neck squamous cell carcinoma
ISRCTN86478952Phase 2Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Jul 2002
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by United States Department of Health and Human Services. Primary endpoint: Tolerability of modestly accelerated radiotherapy with synchronous cisplatin chemotherapy. Started Jul 2002; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on ISRCTN86478952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN86478952.